日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy

评估CD3、CD8和FOXP3 mRNA表达在接受蒽环类药物辅助化疗的早期乳腺癌患者中的预后价值

Tsiatas, Marinos; Kalogeras, Konstantine T; Manousou, Kyriaki; Wirtz, Ralph M; Gogas, Helen; Veltrup, Elke; Zagouri, Flora; Lazaridis, Georgios; Koutras, Angelos; Christodoulou, Christos; Pentheroudakis, George; Petraki, Constantina; Bafaloukos, Dimitrios; Pectasides, Dimitrios; Kosmidis, Paris; Samantas, Epaminontas; Karanikiotis, Charisios; Papakostas, Pavlos; Dimopoulos, Meletios-Athanassios; Fountzilas, George

Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study

评估所有四种 HER 家族受体对接受曲妥珠单抗治疗的转移性乳腺癌患者的预后价值:希腊肿瘤合作组 (HeCOG) 的一项研究

Angelos Koutras, Georgios Lazaridis, Georgia-Angeliki Koliou, George Kouvatseas, Christos Christodoulou, Dimitrios Pectasides, Vassiliki Kotoula, Anna Batistatou, Mattheos Bobos, Eleftheria Tsolaki, Kyriaki Papadopoulou, George Pentheroudakis, Pavlos Papakostas, Stavroula Pervana, Kalliopi Petraki, 

Feasibility of Induction Docetaxel, Cisplatin, 5-Fluorouracil, Cetuximab (TPF-C) Followed by Concurrent Cetuximab Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

局部晚期头颈部鳞状细胞癌诱导多西他赛、顺铂、5-氟尿嘧啶、西妥昔单抗 (TPF-C) 联合西妥昔单抗放射治疗的可行性

Nikolaos Charalambakis, Vassilis Kouloulias, Helena Vaja, Dimitrios Pectasides, Theodoros Rampias, Theofanis Economopoulos, Panagiotis Katsaounis, Spiros Siolos, Valentina Bartzi, Christos Perisanidis, Konstantinos Laschos, Pavlos Maragoudakis, Konstantinos Proikas, Nikolaos Papadimitriou, Nikolaos

Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases

家族性和散发性希腊卵巢癌病例中 BRCA1 突变的流行率

Alexandra V Stavropoulou, Florentia Fostira, Maroulio Pertesi, Marianthi Tsitlaidou, Gerassimos E Voutsinas, Olga Triantafyllidou, Aristotelis Bamias, Meletios A Dimopoulos, Eleni Timotheadou, Dimitrios Pectasides, Christos Christodoulou, George Klouvas, Christos Papadimitriou, Thomas Makatsoris, Ge

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis

XELIRI-贝伐单抗与 FOLFIRI-贝伐单抗作为转移性结直肠癌患者的一线治疗:一项希腊肿瘤合作组 III 期临床试验及其附带生物标志物分析

Dimitrios Pectasides, George Papaxoinis, Konstantine T Kalogeras, Anastasia G Eleftheraki, Ioannis Xanthakis, Thomas Makatsoris, Epaminondas Samantas, Ioannis Varthalitis, Pavlos Papakostas, Nikitas Nikitas, Christos N Papandreou, George Pentheroudakis, Eleni Timotheadou, Angelos Koutras, Joseph Sgo

Correlation of CYP1A1, GSTP1 and GSTM1 gene polymorphisms and lung cancer risk among smokers

CYP1A1、GSTP1 和 GSTM1 基因多态性与吸烟者肺癌风险的相关性

Kyriaki Pliarchopoulou,Gerasimos Voutsinas, George Papaxoinis, Katherine Florou, Maria Skondra, Konstantina Kostaki, Paraskevi Roussou, Konstantinos Syrigos, Dimitrios Pectasides

Multiplex RT-PCR-based detections of CEA, CK20 and EGFR in colorectal cancer patients

基于多重 RT-PCR 检测结直肠癌患者的 CEA、CK20 和 EGFR

Aikaterini Tsouma, Chrysanthi Aggeli, Panagiotis Lembessis, George-N Zografos, Dimitris-P Korkolis, Dimitrios Pectasides, Maria Skondra, Nikolaos Pissimissis, Anastasia Tzonou, Michael Koutsilieris